Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...

OXB to become commercial manufacturer of lentiviral vectors for Bristol Myers Squibb (BMS) CAR-T programmesMulti-year agreement with five-year ...

Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...

This model is suitable for investigating viral pathogenic mechanisms, gene function, and virus-host interactions. It can also be used for testing HPV-related vaccines and developing and validating ...

Explore RNA interference methods, comparing siRNA and shRNA for gene knockdown, their mechanisms, advantages, and implications for molecular biology research.